The Lancet Neurology播客

Laurent Servais and Dora Markati (both from the University of Oxford, UK) discuss emerging therapies for Duchenne muscular dystrophy; their Review is published in the September issue of The Lancet Neurology.由The Lancet

Andreas Charidimou (Massachusetts General Hospital, Boston, MA, USA) discusses an international collaborative study that presents new Boston criteria for diagnosis of cerebral amyloid angiopathy; the Article is published in the August issue of The Lancet Neurology.由The Lancet

Sarah Tabrizi (UCL Queen Square Institute of Neurology, London, UK) and Cristina Sampaio (CHDI Foundation, Princeton, NJ, USA) discuss two papers on Huntington’s disease published in the July issue of The Lancet Neurology: a Position Paper outlining a new classification of the disease, called the Huntington’s Disease Integrated Staging System, and …

Mark Hallett (National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA) discusses his Review, published in the June issue of The Lancet Neurology, on functional neurological disorder, and talks about new subtypes of this disorder, diagnostic challenges, and how education is important.…

Eva Feldman (University of Michigan, Ann Arbor, USA) discusses the latest advances in the genetics, risk factors, pathophysiology, therapeutic development, and the diagnosis and prognosis of amyotrophic lateral sclerosis; the Series is published in the May issue of The Lancet Neurology.由The Lancet

Estrella Morenas-Rodriguez and Christian Haass (German Centre for Neurodegenerative Diseases, Munich, Germany) discuss their recent research, published in the April issue of The Lancet Neurology, on soluble TREM2 and its association with Alzheimer’s disease biomarkers and cognition.由The Lancet

John Collinge (MRC Prion Unit, University College London, London, UK) discusses a first-in-human treatment programme to give PRN100, an anti-prion-protein monoclonal antibody, to patients with Creutzfeldt–Jakob disease; the report is published in the April issue of The Lancet Neurology.由The Lancet

Alexandra Durr (Paris Brain Institute, Pitié-Salpêtrière Paris, France) discusses the ATRIL study, a randomised trial of riluzole in patients with spinocerebellar ataxia type 2, which is published in the March issue of The Lancet Neurology.由The Lancet

Giuseppe Citerio (University of Milano-Bicocca, Milan, Italy) discusses the implications of a study from the CENTER-TBI project of the effect of frailty on 6-month outcome after traumatic brain injury, which is published in the February issue of The Lancet Neurology.由The Lancet

Alberto Costa (Case Western Reserve University, Cleveland, OH, USA) discusses his study on the use of memantine in adolescents and young adults with Down syndrome, which is published in the January issue of The Lancet Neurology.由The Lancet

Olivier Rascol (Toulouse University, France) discusses the uses of amantadine in the treatment of patients with movement disorders, which are the focus of his Personal View in the December issue of The Lancet Neurology.由The Lancet

Antonio Uccelli (University of Genoa) discusses his research, published in the November issue of The Lancet Neurology, on the therapeutic use of mesenchymal stem cells for multiple sclerosis.由The Lancet

Priya Palta (Columbia University, New York) explains the importance of blood pressure control in the prevention of cognitive decline. Her Review, published in the October issue of The Lancet Neurology, provides an update of the mounting evidence that links hypertension with dementia risk.由The Lancet

Adam Boxer (University of California, San Francisco) discusses his research, published in the September issue of The Lancet Neurology, on diagnostic performance of tau biomarkers in neurodegenerative diseases.由The Lancet

Irene Cortese (National Institute of Neurological Disorders and Stroke) discusses the difficulties of designing clinical trials in progressive multifocal leukoencephalopathy.由The Lancet

Doug Turnbull (University of Newcastle) discusses mitochondrial diseases in adults, which are reviewed in the July issue of The Lancet Neurology, and explains how important these diseases are for neurologists.由The Lancet

Geert Jan Biessels (University Medical Centre Utrecht) discusses his research, published in The Lancet Neurology June issue, on using strategic infarct locations to predict post-stroke cognitive impairment.由The Lancet

Henk-Jan Westeneng discusses his new work on the causal effects of pre-symptomatic lifestyle on ALS.由The Lancet

Bruce Campbell joins The Lancet Neurology to discuss his systematic review of the HERMES collaboration.由The Lancet

Anne MacGregor discusses her recent Review of menstrual migraine, and explains why this disease needs greater recognition.由The Lancet

Peter Rothwell (Oxford University) discusses his new research, found in our new issue, on asymptomatic carotid stenosis and stroke.由The Lancet

Professor Michael Fehlings discusses the implications of his two papers in the Feb 2021 issue of The Lancet Neurology.由The Lancet

Emma Jones and Simon Mead discuss their article in The Lancet Neurology, identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease.由The Lancet

Mark Obermann discusses his study examining the use of prednisone for the short-term prevention of cluster headache.由The Lancet

Robert Innis discusses his work on measuring neuroinflammation using PET imaging.由The Lancet

Tom Solomon discusses his Rapid Review on neurologically-associated COVID-19 problems, in The Lancet Neurology.由The Lancet

Huda Zoghbi discusses the prospects for future therapies in Rett syndrome.由The Lancet

Bas Bloem chats about his new research into a network model for reshaping chronic neurological care for patients with Parkinson's disease.由The Lancet

Sarah Tabrizi discusses her new research into analysing the early onset of Huntington's Disease.由The Lancet

Meng-Chuan Lai discusses the current evidence base for supporting autistic people.由The Lancet

Tobias Derfuss discusses his rapid review on advances in oral immunomodulating therapies in relapsing multiple sclerosis.由The Lancet

Andrea Winkler discusses the global burden caused by stroke, epilepsy, dementia, and neuroinfections, and what low- and middle-income countries can do.由The Lancet

Jonathan Schott discusses the associations between blood pressure across adulthood and late-life brain structure and pathology.由The Lancet

Jeffrey Wozniak talks about his Review in The Lancet Neurology, on clinical presentation, diagnosis, and management of fetal alcohol spectrum disorder.由The Lancet

Martin Dichgans discusses advancements in the field of stroke genetics.由The Lancet

Brent Fogel talks to The Lancet Neurology about his work on large-scale genomic analysis.由The Lancet

Amaia Arranz and Bart De Strooper discuss their Review on the role of astroglia in Alzheimer's disease.由The Lancet

Michael Irwin (University of California, Los Angeles, USA) discusses a Review concerning potential links of sleep disturbance and possible increased risk of Alzheimer's disease dementia.由The Lancet

Lindsay Wallace and Kenneth Rockwood join The Lancet Neurology to talk about their work on the association between frailty and the onset of Alzheimer's disease.由The Lancet

In the latest podcast from The Lancet Neurology, Jan Scheitz discusses the development of stroke–heart syndrome.由The Lancet

Mark Cook and Phillippa Karoly join The Lancet Neurology to discuss their retrospective study of cyclical patterns in epileptic seizures.由The Lancet

Bruce Trapp and Daniel Ontaneda discuss their retrospective study investigating cortical neuronal loss and cerebral white-matter demyelination in mulitple sclerosis.由The Lancet

Josep Dalmau joins The Lancet Neurology to discuss recognition and outcomes of autoimmune encephalitis after herpes simplex encephalitis.由The Lancet

David Eidelberg and Katharina Schindelbeck join The Lancet Neurology to explain their new review of the applications of network imaging biomarkers in Parkinson's disease.由The Lancet

Eugene Major and David Clifford join The Lancet Neurology to discuss their review of pathogenesis and treatments for progressive multifocal leukoencephalopathy.由The Lancet

Torbjörn Tomson discusses the issue of antiepileptic drugs during pregnancy and the risk of major congenital malformations.由The Lancet

Christian Elger discusses the diagnostic challenges in epilepsy with the detection and reporting of seizures.由The Lancet

Jeffrey Cohen joins us to talk about the process of updating and revising the McDonald criteria for diagnosis of MS.由The Lancet

Jose Bras discusses his study of the genetic architecture of dementia with Lewy bodies.由The Lancet

Andrew Maas and David Menon, lead authors, discuss The Lancet Neurology Commission on traumatic brain injury and outline the worldwide burden.由The Lancet